New antibody appears to re-activate immune system in cancer therapy

(Duke University Medical Center) Adding an investigational antibody to the chemotherapy rituximab appears to restore its cancer-killing properties in certain leukemia patients with a natural resistance to the drug, according to a small, proof-of-concept study by Duke Cancer Institute researchers. (Source: EurekAlert! - Cancer)

from MedWorm via o.lakala70 on Inoreader http://ift.tt/2u0hosC
via IFTTT